Currently predicting for Wed, 1 May 2024

Trading levels for KALV

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 11.70 3.11 %
R2 11.52 1.50 %
R1 11.41 0.500 %
Current price: 11.35
Support S1 11.04 -2.73 %
S2 10.93 -3.73 %
S3 10.74 -5.35 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 13.80 21.59 %
R2 12.58 10.84 %
R1 11.86 4.49 %
Current price 11.35
Support S1 11.21 -1.23%
S2 11.11 -2.11%
S3 11.04 -2.73%

KALV Predictions History

3 years ago
JS predicted that KALV for 2020-10-15 is going $14.46 (-5.92%)

4 years ago
JS predicted that KALV for 2020-02-07 is going $15.66 (0.71%)

4 years ago
2poJeff predicted that KALV for 2020-02-07 is going $16.48 (3.52%)

4 years ago
Aldrik Kleinlooh predicted that KALV for 2020-02-07 is going

Rank:

4 years ago
NameNotImportant predicted that KALV for 2019-05-06 is going $21.25 (-4.62%)

5 years ago
NameNotImportant predicted that KALV for 2019-04-29 is going $24.49 (6.43%)

6 years ago
JS predicted that KALV for 2017-10-23 is going $11.49 (-11.75%)

Click to get the best stock tips daily for free!

About KalVista Pharmaceuticals Inc

KalVista Pharmaceuticals KalVista Pharmaceuticals, Inc., a clinical stage pharmaceutical company, discovers, develops, and commercializes small molecule protease inhibitors for diseases with unmet needs. The company's product portfolio comprises small molecule plasma kallikrein inhibitors targeting hereditary angioedema (HAE) and diabetic macular edema (DME); and oral plasma kallikrein inhibitors. Its products include KVD001, a plasma kallikrein inhibitor that completed ... KALV Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT